Does IPILIMUMAB Cause Transplant rejection? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Transplant rejection have been filed in association with IPILIMUMAB (YERVOY). This represents 0.0% of all adverse event reports for IPILIMUMAB.
7
Reports of Transplant rejection with IPILIMUMAB
0.0%
of all IPILIMUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Transplant rejection From IPILIMUMAB?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.
Is Transplant rejection Listed in the Official Label?
Yes, Transplant rejection is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which IPILIMUMAB Alternatives Have Lower Transplant rejection Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN